The use of cardiovascular system medicine in Germany has steadily increased from 2013 to 2023. In 2023, it reached 836.6 units (defined daily dosage) per thousand persons per day. The observed trends reflect a consistent growth with varying year-on-year percentages, ranging from a high of 4.76% in 2019 to lower increments around 1% earlier in the decade. The compound annual growth rate (CAGR) over the past five years leading up to 2023 is 3.05%, indicating robust market expansion.
Looking ahead from 2024 to 2028, the forecast predicts a continued albeit slower growth rate with a forecasted 5-year CAGR of 1.5% and an overall growth rate of 7.74%. This suggests a deceleration in the rapid increase seen in previous years, but the trend remains positive, driven by an aging population and ongoing advancements in cardiovascular treatments.
Future trends to watch for include:
- Technological innovations in cardiovascular treatments and their impact on medicine use.
- The effect of healthcare policies and preventive measures reducing the necessity for cardiovascular medications.
- Shifts in demographics and lifestyle that may influence the incidence of cardiovascular diseases.
